Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,737
Closed -$468K 83
2019
Q3
$468K Hold
13,737
0.01% 73
2019
Q2
$565K Sell
13,737
-812,760
-98% -$32.3M 0.01% 76
2019
Q1
$33.3M Hold
826,497
0.42% 22
2018
Q4
$34.2M Buy
826,497
+131,162
+19% +$5.44M 0.5% 24
2018
Q3
$29.1M Buy
695,335
+146,661
+27% +$5.65M 0.37% 24
2018
Q2
$18.9M Sell
548,674
-30,371
-5% -$1.04M 0.26% 27
2018
Q1
$19.5M Hold
579,045
0.3% 26
2017
Q4
$19.9M Hold
579,045
0.29% 27
2017
Q3
$19.6M Sell
579,045
-21,948
-4% -$705K 0.28% 29
2017
Q2
$19.2M Sell
600,993
-198,688
-25% -$6.27M 0.29% 31
2017
Q1
$26M Hold
799,681
0.44% 22
2016
Q4
$24.6M Buy
799,681
+52,485
+7% +$1.6M 0.48% 25
2016
Q3
$24M Sell
747,196
-463,760
-38% -$15.5M 0.42% 28
2016
Q2
$40.5M Hold
1,210,956
0.77% 19
2016
Q1
$34.1M Hold
1,210,956
0.66% 21
2015
Q4
$37.1M Buy
1,210,956
+637,670
+111% +$20.1M 0.65% 23
2015
Q3
$17.1M Sell
573,286
-16,232
-3% -$520K 0.29% 33
2015
Q2
$18.8M Sell
589,518
-502,758
-46% -$16.4M 0.27% 35
2015
Q1
$36.1M Hold
1,092,276
0.51% 24
2014
Q4
$32.3M Sell
1,092,276
-59,487
-5% -$1.71M 0.48% 23
2014
Q3
$32.8M Buy
+1,151,763
New +$32.3M 0.48% 21

Other funds holding PFE

C WorldWide Group's PFE Position: Q4 2019 in Review

C WorldWide Group sold out of Pfizer (PFE) in Q4 2019, closing a stake of 13,737 shares — an estimated $468K sold.

C WorldWide Group first reported a position in PFE in Q3 2014 and held it in 21 quarters. The position peaked at $40.5M in Q2 2016. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • C WorldWide Group reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
  • C WorldWide Group sold 13,737 Pfizer shares in Q4 2019, an estimated $468K.
  • C WorldWide Group first reported a position in Pfizer in Q3 2014 and held it in 21 quarters.
  • C WorldWide Group's Pfizer position peaked at $40.5M in Q2 2016.
  • 2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on C WorldWide Group's 13F filing for Q4 2019, filed 5 Feb 2020.